BioTheryX to Present at 2021 RBC Capital Markets Global Healthcare Conference

BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, today announced that…

Theravance Biopharma, Inc. Reports First Quarter 2021

Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today reported financial results for the first…

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted…

Medifast, Inc. Announces First Quarter 2021 Financial Results

 Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported…

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing…

Everest Medicines Receives Orphan Drug Designation from the Ministry of Food and Drug Safety in South Korea

 Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products in Greater…

Gentle Dental Ballard Relocates to Spacious State-of-the-Art Facility

 Gentle Dental, a full service dental provider with nearly 165 locations nationwide, is relocating it’s Ballard, Washington location…

Encompass Health extends national Together To End Stroke® sponsorship with the American Stroke Association for an additional three years

Today, Encompass Health (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the U.S.…

Apollo Medical Holdings, Inc. Reports First Quarter 2021 Results

Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH),…

Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

 Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that, effective on May 1, 2021, the Compensation Committee of Blueprint…